正文 第一節 前沿學術綜述(2 / 3)

19.Batchinsky Al.Jordan BS.Regn D,et al.Respiratory dialysis:reduction in dependence on mechanical ventilation by venovenous extracorporeal C(emoval.Crit Care Med.2011.39(6):1382-1387.

20.Cardenas VJ Jr.Miller L.Lynch JE,et al.Percutaneous venovenous C()2 removal with regional anticoagulation in an ovine mod el.ASAIO J.2006.52(4):467-470.

21.Doll N,Kiaii B.Borger M,et al.Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock.Ann Thorac Surg.2004.77(1):151-157;discussion 157.

22.Elsharkawy HA Li L.Esa WA.et al.Outcome in patients who require venoarterial extracorporeal membrane oxygenation support after cardiac surgery.J Cardiothorac Vase Anesth.2010.24(6):946-951.

23.Kumar 丁K.Zurakowski D.Dalton H.et al.Extracorporeal membrane oxygenation in postcardiotomy patients:factors influencing outcome.J Thorac Cardiovasc Surg.2010.140(2):330-336.e2.

24.Acker MA.Mechanical circulatory support for patients with acut^fulminant myocarditis.Ann Thorac Surg.2001.71(3 Suppl):S73-76;discussion S82-85.

25.Kawahito K.Murata S.Adachi H.et al.Resuscitation and circulatory support using extracorporeal membrane oxygenation for fulminant pulmonary embolism.Artif Organs.2000.24(6):427-430.

26.Chen YS,Lin JW.Yu HY.et al.Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest:an observational study and propensityanalysis.Lancet.2008.372(9638):554-561.

27.Baud FJ.Megarbane 13,Deye N,Leprince P.Clinical review:aggressive management and extracorporeal support for drug-induced cardiotoxicity.Crit Care.2007.11(2):207.

28.Watson WA,Litovitz TL.Klein-Schwartz W.et al.2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.Am J Emerg Med 2004.22(5):335-404.

29.Fortenberry JD.Paden ML.Extracorporeal therapies in the treatment of sepsis:experience and promise.Semin Pcdiatr Infect Dis.2006.17(2):72-79.

30.Vohra HA,Adamson L.Wccden DF.Haw VIP.Use of extracorporeal membrane oxygenation in the management of septic shock with severe cardiac dysfunction after Ravitch procedure.Ann Thorac Surg.2009.87(1):e4-5.

31.Li J.Long C,Lou S,et al.Venoarterial extracorporeal membrane oxygenation in adult patients:prcdictors of mortality.Perfusion.2009.24(4):225-230.

32.龍村,當今體外膜肺氧合趨勢和對中國的兒點建議,中國體外循環雜誌.2010.8(1):1-3.

33.Mottaghy K.()edckoven 13.Poppel K.et al.Heparin free long-term extracorporeal circulation using bioactive surfaces.ASAIO Trans.1989.35(3):635-637.

34.Plotz FB.van()W.Bartlett RH.Wildevuur CR.Blood activation during neonatal extracorporeal life support.J Thorac Cardiovasc Surg.1993.105(5):823-832.

35.Hocker JR.Well hausen SR.Ward RA,et al.Effect of extracorporeal membrane oxygenation on leukocyte function in neonates.Artif Organs.1991.15(1):23-28.

36.Robinson TM.Kicklcr TS,Walker LK.et al.Effect of extracorporeal membrane oxygenation on platelets in newborns.Crit Care Med.1993.21(7):1029-1034.